A preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.
Published
Journal Article
Full Text
Duke Authors
Cited Authors
- Bullard, DE; Thomas, DG; Darling, JL; Wikstrand, CJ; Diengdoh, JV; Barnard, RO; Bodmer, JG; Bigner, DD
Published Date
- February 1985
Published In
Volume / Issue
- 51 / 2
Start / End Page
- 283 - 289
PubMed ID
- 3966985
Pubmed Central ID
- 3966985
International Standard Serial Number (ISSN)
- 0007-0920
Digital Object Identifier (DOI)
- 10.1038/bjc.1985.41
Language
- eng
Conference Location
- England